Is Jasper Therapeutics, Inc. (JSPR) a Buy, Sell, or Hold?
Jasper Therapeutics, Inc.
NASDAQ:JSPR
$0.7228 USD
$0.11 (18.9%)
- Volume
- 3.12M
- Average Volume
- 501.05K
- Market Capitalization
- $11.75M
- P/E Ratio
- -0.21
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $3.53
- Year Low
- $0.32
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.26
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-75.9% DOWNSIDE
$3.00 Price Target
UPSIDE/DOWNSIDE HIGH
-75.9% DOWNSIDE
$3.00 Price Target High
UPSIDE/DOWNSIDE LOW
-75.9% DOWNSIDE
$3.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Gregory Renza | $48 | $17.71 | 2025-01-09 06:19 AM | 171.0% |
| BMO Capital | Etzer Darout | $63 | $21.53 | 2024-12-05 04:06 PM | 192.6% |
| H.C. Wainwright | Emily Bodnar | $65 | $24.52 | 2024-05-06 02:06 AM | 165.1% |
| Evercore ISI | Gavin Clark-Gartner | $65 | $26.2 | 2024-04-03 02:38 AM | 148.1% |